These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10707831)

  • 1. Mola invasiva--special form of GTD.
    Danihel L; Zaviacic M; Korbel M; Vojtassák J; Repiská V; Breitenecker G; Böhmer D; Hatzibougias I
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():37-41. PubMed ID: 10707831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
    Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
    Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of cellular DNA and RNA contents of hydatidiform mole. Two significant parameters indicating malignant nature and prognosis.
    Yin GP; Su YK
    Chin Med J (Engl); 1993 Feb; 106(2):136-40. PubMed ID: 8389273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic neoplasms in homozygous twins.
    La Vecchia C; Franceschi S; Fasoli M; Mangioni C
    Obstet Gynecol; 1982 Aug; 60(2):250-2. PubMed ID: 6296738
    [No Abstract]   [Full Text] [Related]  

  • 5. [Principles of prophylaxis, early detection, treatment and follow-up of gestational trophoblastic tumors].
    Ebeling K; Sarembe B
    Zentralbl Gynakol; 1988; 110(22):1401-6. PubMed ID: 2464881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MMP-2/TIMP-2 expression in the trophoblasts of patients with gestational trophoblastic disease].
    Ding F; Zhang QS; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):150-2. PubMed ID: 17355922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of patients with lung metastasis of invasive mole before evacuation of hydatidiform mole].
    Feng FZ; Xiang Y; Shan Y; Wan XR; Oang XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):830-3. PubMed ID: 18476517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of the novel hydatidiform mole-related gene F10 with the invasiveness of trophoblastic tumor].
    Zhou J; Chen SL; Xing FQ; Pang ZJ; Li B; Zhou WQ; Fu X; Ding YQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):171-3. PubMed ID: 15698997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydatidiform mole metastasizing to the lung.
    Band PR; Masse SR; Reid DW; Dossetor JB
    Can Med Assoc J; 1976 May; 114(9):813-4. PubMed ID: 178421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Invasive hydatiform mole in a postmenopausal woman].
    de la Fouchardière A; Cassignol A; Benkiran L; Rudigoz RC; Gougeon A; Devouassoux-Shisheboran M
    Ann Pathol; 2003 Oct; 23(5):443-6. PubMed ID: 14752389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual trophoblastic disease in association with partial hydatidiform mole.
    Szulman AE; Ma HK; Wong LC; Hsu C
    Obstet Gynecol; 1981 Mar; 57(3):392-4. PubMed ID: 6258115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of epidermal growth factor in gestational trophoblastic disease (GTD).
    John M; Rajalekshmy TN; Nair MB; Augustine J; Schultz G; Nair MK; Balaram P
    J Exp Clin Cancer Res; 1997 Jun; 16(2):129-34. PubMed ID: 9261736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative analysis of the cellular DNA and RNA contents of hydatidiform mole and its clinical significance].
    Yin GP; Su YK; Zhuang GX
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):538-41, 574. PubMed ID: 7835131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
    Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
    Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese trial for classification of gestational trophoblastic disease.
    Sasaki S; Sasaki Y
    J Reprod Med; 2008 Aug; 53(8):583-8. PubMed ID: 18773622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current approaches to diagnosis and treatment of gestational trophoblastic disease.
    Smith DB; O'Reilly SM; Newlands ES
    Curr Opin Obstet Gynecol; 1993 Feb; 5(1):84-91. PubMed ID: 8381037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive partial mole.
    Gaber LW; Redline RW; Mostoufi-Zadeh M; Driscoll SG
    Am J Clin Pathol; 1986 Jun; 85(6):722-4. PubMed ID: 3010701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.